Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
A New Form of Fentanyl

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 26(11)
Publications
Page Number
E3
Legacy Keywords
fentanyl, buccal soluble film, FBSF, Onsolis, opioid, cancer, pain, breakthrough, risk evaluation mitigation strategy, REMS, full ongoing compliance system, FOCUS, FDAfentanyl, buccal soluble film, FBSF, Onsolis, opioid, cancer, pain, breakthrough, risk evaluation mitigation strategy, REMS, full ongoing compliance system, FOCUS, FDA
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 26(11)
Issue
Federal Practitioner - 26(11)
Page Number
E3
Page Number
E3
Publications
Publications
Article Type
Display Headline
A New Form of Fentanyl
Display Headline
A New Form of Fentanyl
Legacy Keywords
fentanyl, buccal soluble film, FBSF, Onsolis, opioid, cancer, pain, breakthrough, risk evaluation mitigation strategy, REMS, full ongoing compliance system, FOCUS, FDAfentanyl, buccal soluble film, FBSF, Onsolis, opioid, cancer, pain, breakthrough, risk evaluation mitigation strategy, REMS, full ongoing compliance system, FOCUS, FDA
Legacy Keywords
fentanyl, buccal soluble film, FBSF, Onsolis, opioid, cancer, pain, breakthrough, risk evaluation mitigation strategy, REMS, full ongoing compliance system, FOCUS, FDAfentanyl, buccal soluble film, FBSF, Onsolis, opioid, cancer, pain, breakthrough, risk evaluation mitigation strategy, REMS, full ongoing compliance system, FOCUS, FDA
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media